| Literature DB >> 34341531 |
Kevin G Chen1, Kyeyoon Park2, Jason R Spence3,4,5.
Abstract
Clinical management of patients with severe complications of COVID-19 has been hindered by a lack of effective drugs and a failure to capture the extensive heterogeneity of the disease with conventional methods. Here we review the emerging roles of complex organoids in the study of SARS-CoV-2 infection, modelling of COVID-19 disease pathology and in drug, antibody and vaccine development. We discuss opportunities for COVID-19 research and remaining challenges in the application of organoids.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34341531 PMCID: PMC8355201 DOI: 10.1038/s41556-021-00721-x
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824